BACKGROUND: HIV-associated neurocognitive disorder persists in some people living with HIV despite optimal antiretroviral therapy. Latent tuberculosis infection (LTBI) may cause systemic inflammation and immune activation that may impair brain function. We assessed cognition and biomarkers of inflammation in both HIV+ and HIV- South Indians with and without LTBI. METHODS: Adults (≥18 years old) with and without HIV infection were screened for LTBI by interferon-gamma release assays, completed comprehensive neurocognitive assessments, and underwent measurement of serum inflammatory biomarker levels. RESULTS: The participants (n = 119) were HIV+/LTBI+ (n = 15), HIV+/LTBI- (n = 50), HIV-/LTBI+ (n = 26), and HIV-/LTBI- (n = 28). HIV+ participants, regardless of LTBI status, had more impaired global deficit scores than HIV- participants (odds ratio = 3.42, P = 0.028, adjusted for sex and education differences). Neither global deficit scores nor impairment rates differed in the LTBI+ group compared with the LTBI- group (P = 0.79 and P = 0.41, respectively). The mean log10 interleukin (IL)-6 and monocyte chemoattractant protein-1 values were significantly higher and high sensitivity C-reactive protein lower in the LTBI+ group than the LTBI- group (P = 0.044, 0.023, and 0.03, respectively, adjusting for HIV status and sex). CONCLUSIONS: In this cross-sectional study of South Indians, HIV infection, but not LTBI, was associated with increased neurocognitive impairment. Proinflammatory biomarkers (IL-6 and monocyte chemoattractant protein-1, but not tumor necrosis factor-α) were elevated in the LTBI+ groups compared with the LTBI- groups. Biomarkers of immune activation (interferon-γ, macrophage inflammatory protein-1β, IL-2, interferon gamma inducible protein-10, RANTES, and IL-22) did not differ between these groups. Larger longitudinal studies should be conducted to confirm our findings that the effect of LTBI on systemic inflammation or neurocognitive impairment is likely small.
BACKGROUND: HIV-associated neurocognitive disorder persists in some people living with HIV despite optimal antiretroviral therapy. Latent tuberculosis infection (LTBI) may cause systemic inflammation and immune activation that may impair brain function. We assessed cognition and biomarkers of inflammation in both HIV+ and HIV- South Indians with and without LTBI. METHODS: Adults (≥18 years old) with and without HIV infection were screened for LTBI by interferon-gamma release assays, completed comprehensive neurocognitive assessments, and underwent measurement of serum inflammatory biomarker levels. RESULTS: The participants (n = 119) were HIV+/LTBI+ (n = 15), HIV+/LTBI- (n = 50), HIV-/LTBI+ (n = 26), and HIV-/LTBI- (n = 28). HIV+ participants, regardless of LTBI status, had more impaired global deficit scores than HIV- participants (odds ratio = 3.42, P = 0.028, adjusted for sex and education differences). Neither global deficit scores nor impairment rates differed in the LTBI+ group compared with the LTBI- group (P = 0.79 and P = 0.41, respectively). The mean log10 interleukin (IL)-6 and monocyte chemoattractant protein-1 values were significantly higher and high sensitivity C-reactive protein lower in the LTBI+ group than the LTBI- group (P = 0.044, 0.023, and 0.03, respectively, adjusting for HIV status and sex). CONCLUSIONS: In this cross-sectional study of South Indians, HIV infection, but not LTBI, was associated with increased neurocognitive impairment. Proinflammatory biomarkers (IL-6 and monocyte chemoattractant protein-1, but not tumor necrosis factor-α) were elevated in the LTBI+ groups compared with the LTBI- groups. Biomarkers of immune activation (interferon-γ, macrophage inflammatory protein-1β, IL-2, interferon gamma inducible protein-10, RANTES, and IL-22) did not differ between these groups. Larger longitudinal studies should be conducted to confirm our findings that the effect of LTBI on systemic inflammation or neurocognitive impairment is likely small.
Authors: Catherine L Carey; Steven Paul Woods; Julie D Rippeth; Raul Gonzalez; David J Moore; Thomas D Marcotte; Igor Grant; Robert K Heaton Journal: Clin Neuropsychol Date: 2004-05 Impact factor: 3.535
Authors: Kevin R Robertson; Bibilola Oladeji; Hongyu Jiang; Johnstone Kumwenda; Khuanchai Supparatpinyo; Thomas B Campbell; James Hakim; Srikanth Tripathy; Mina C Hosseinipour; Christina M Marra; Nagalingeswaran Kumarasamy; Scott Evans; Alyssa Vecchio; Alberto La Rosa; Breno Santos; Marcus T Silva; Sylvia Montano; Cecilia Kanyama; Cindy Firnhaber; Richard Price; Cheryl Marcus; Baida Berzins; Reena Masih; Umesh Lalloo; Ian Sanne; Sarah Yosief; Ann Walawander; Aspara Nair; Ned Sacktor; Colin Hall Journal: Clin Infect Dis Date: 2019-05-02 Impact factor: 9.079
Authors: María J Marquine; Anya Umlauf; Alexandra S Rooney; Pariya L Fazeli; Ben D Gouaux; Steven Paul Woods; Scott L Letendre; Ronald J Ellis; Igor Grant; David J Moore Journal: J Acquir Immune Defic Syndr Date: 2014-02-01 Impact factor: 3.731
Authors: Batool A Haider; Donna Spiegelman; Ellen Hertzmark; David Sando; Christopher Duggan; Abel Makubi; Christopher Sudfeld; Eric Aris; Guerino E Chalamilla; Wafaie W Fawzi Journal: Am J Trop Med Hyg Date: 2019-06 Impact factor: 2.345
Authors: Fred R Sattler; Jiaxiu He; Scott Letendre; Cara Wilson; Chelsea Sanders; Robert Heaton; Ronald Ellis; Donald Franklin; Grace Aldrovandi; Christina M Marra; David Clifford; Susan Morgello; Igor Grant; J Allen McCutchan Journal: J Acquir Immune Defic Syndr Date: 2015-03-01 Impact factor: 3.771
Authors: Zuri A Sullivan; Emily B Wong; Thumbi Ndung'u; Victoria O Kasprowicz; William R Bishai Journal: EBioMedicine Date: 2015-04-01 Impact factor: 8.143
Authors: Moises A Huaman; David Henson; Paola L Rondan; Eduardo Ticona; Gustavo Miranda; Richard J Kryscio; Raquel Mugruza; Ernesto Aranda; Cesar Ticona; Susan Abarca; Paula Heredia; Andres Aguirre; Timothy R Sterling; Beth A Garvy; Carl J Fichtenbaum Journal: PLoS One Date: 2018-09-13 Impact factor: 3.240
Authors: John Walles; Laura García Otero; Fregenet Tesfaye; Asmamaw Abera; Marianne Jansson; Taye Tolera Balcha; Erik Sturegård; Niclas Winqvist; Stefan R Hansson; Per Björkman Journal: PLoS One Date: 2022-04-11 Impact factor: 3.240
Authors: Monica M Diaz; Marcela Gil Zacarías; Patricia Sotolongo; María F Sanes; Donald J Franklin; María J Marquine; Mariana Cherner; Cesar Cárcamo; Ronald J Ellis; Serggio Lanata; Patricia J García Journal: Front Neurol Date: 2021-06-17 Impact factor: 4.086